Evidence map›Paper›PMID 15956557›Full record

ArticleJournal of virology2005

Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.

Barbara L Lohman, Jennifer A Slyker, Barbra A Richardson, Carey Farquhar, Jenniffer M Mabuka, Christopher Crudder, Tao Dong, Elizabeth Obimbo, Dorothy Mbori-Ngacha, Julie Overbaugh and 2 more

Abstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Dissecting the defects in the neonatal CD8Journal of leukocyte biology · 2019
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Immunity to cytomegalovirus in early life.Frontiers in immunology · 2014
    Review
  13. Immunity to HIV in Early Life.Frontiers in immunology · 2014
    Review
  14. Immunology of pediatric HIV infection.Immunological reviews · 2013
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Barbara L LohmanDepartment of Paediatrics, University of Nairobi, Kenya. bllohman@iconnect.co.ke
Jennifer A Slyker
Barbra A Richardson
Carey Farquhar
Jenniffer M Mabuka
Christopher Crudder
Tao Dong
Elizabeth Obimbo
Dorothy Mbori-Ngacha
Julie Overbaugh
Sarah Rowland-Jones
Grace John-Stewart
University of Nairobi · KEFaculty of Public Health · GBInstitute of Molecular Medicine · INUniversity of Washington · USMRC Human Immunology Unit · GB

Funding

INTERNATIONAL TRAINING GRANT IN EPIDEMIOLOGYD43TW000007 · FIC · UNIVERSITY OF WASHINGTON · PI FARQUHAR, CAREY · 1988 to 2012
$16.3M
Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infectionsR01HD023412 · NICHD · UNIVERSITY OF WASHINGTON · PI Grace C. John-Stewart, DALTON CHEKOKO WAMALWA · 1987 to 2026
$12.2M
Vertical CMV transmission in the setting of maternal HIV-1 infection in KenyaK01AI087369 · NIAID · UNIVERSITY OF WASHINGTON · PI SLYKER, JENNIFER ANN · 2010 to 2014
$616k
CTL responses in HIV-1 infected infantsK01TW006080 · FIC · UNIVERSITY OF WASHINGTON · PI PAYNE, BARBARA LOUISE · 2002 to 2005
$495k
FIC NIH HHS D43 TW000007FIC NIH HHS D43 TW00007FIC NIH HHS K01 TW006080FIC NIH HHS TW06080NIAID NIH HHS K01 AI087369NICHD NIH HHS HD23412-14NICHD NIH HHS R01 HD023412
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) infection results in different patterns of viral replication in pediatric compared to adult populations. The role of early HIV-1-specific responses in viral control has not been well defined, because most studies of HIV-1-infected infants have been retrospective or cross-sectional. We evaluated the association between HIV-1-specific gamma interferon (IFN-gamma) release from the cells of infants of 1 to 3 months of age and peak viral loads and mortality in the first year of life among 61 Kenyan HIV-1-infected infants. At 1 month, responses were detected in 7/12 (58%) and 6/21 (29%) of infants infected in utero and peripartum, respectively (P = 0.09), and in approximately 50% of infants thereafter. Peaks of HIV-specific spot-forming units (SFU) increased significantly with age in all infants, from 251/10(6) peripheral blood mononuclear cells (PBMC) at 1 month of age to 501/10(6) PBMC at 12 months of age (P = 0.03), although when limited to infants who survived to 1 year, the increase in peak HIV-specific SFU was no longer significant (P = 0.18). Over the first year of life, infants with IFN-gamma responses at 1 month had peak plasma viral loads, rates of decline of viral load, and mortality risk similar to those of infants who lacked responses at 1 month. The strength and breadth of IFN-gamma responses at 1 month were not significantly associated with viral containment or mortality. These results suggest that, in contrast to HIV-1-infected adults, in whom strong cytotoxic T lymphocyte responses in primary infection are associated with reductions in viremia, HIV-1-infected neonates generate HIV-1-specific CD8+-T-cell responses early in life that are not clearly associated with improved clinical outcomes.

Indexed as

Amino Acid SequenceAntiviral AgentsCD8-Positive T-LymphocytesFemaleHIV-1HIV InfectionsHumansInfantInfectious Disease Transmission, VerticalInterferon-gammaKenyaPeptide FragmentsPregnancyPregnancy Complications, InfectiousViral LoadAntiviral AgentsInterferon-gammaPeptide Fragments

Identifiers

PMID15956557
PMCPMC1143755
OpenAlexW2142124450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.